Table 1.
Measures of chronical ankle instability in the subjects before and after supplementation with SCP or placebo.
| Parameter | Group | t1 Mean | t1 SD | t2 Mean | t2 SD | ANOVA |
|---|---|---|---|---|---|---|
| CAIT (Score) | TG | 15.48† | 4.86 | 20.76*** | 5.42 | < 0.05 |
| PG | 20.80 | 4.77 | 21.45 | 4.18 | ||
| FAAM-G ADL (%) | TG | 81.56† | 12.79 | 91.32*** | 9.91 | < 0.05 |
| PG | 90.28 | 9.29 | 91.44 | 8.13 | ||
| FAAM-G Sport (%) | TG | 60.48† | 18.43 | 80.36*** | 16.90 | < 0.05 |
| PG | 76.24 | 18.15 | 76.52 | 18.10 | ||
| Stiffness (N/mm) | TG | 9.12 | 4.65 | 9.19 | 4.45 | NS |
| PG | 9.62 | 2.97 | 8.85 | 2.89 |
NS, not significant.
* p < 0.05 within the group from baseline to final examination
** p < 0.005 within the group from baseline to final examination
*** p <0.001 within the group from baseline to final examination.
† significant difference at baseline between treatment group and placebo group (p < 0.05).